Scientific Team

TheraVectys benefits from the experience of greatest specialist in Lentiviral vectors
which peer-reviewed papers have paved the way to gene therapy.

Dr. Menez-Jamet serves as Chief Scientific Officer, responsible for managing scientific strategy and R&D execution, ensuring innovation and operational excellence in pre-clinical and clinical programs, and overseeing compliance, partnerships, and alignment of R&D with business objectives. She brings over 20 years of experience in preclinical development and biotechnology, specializing in the transition of products from preclinical stages to clinical trials. Her expertise spans toxicological study design, preclinical CMC management, immunomonitoring, and overseeing Phase I–IIb clinical studies, along with vaccine candidate design and in vivo/in vitro research direction. Prior to joining the company, she served as head of preclinical development at VAXON Biotech. She holds a doctorate in molecular genetics from AgroParisTech, Paris-Saclay University.

Dr. Nemirov serves as Chief Project Manager, responsible for managing the multidisciplinary research team, ensuring operational excellence in daily business activities, contributing to project design and implementation, supporting project proposals, and integrating the latest scientific advancements into research protocols. He brings over 20 years of experience in virology and infectious disease research, having served as a researcher at the Swedish Institute for Infectious Disease Control, the French National Institute of Health and Medical Research, and Institut Pasteur in France. He holds a master’s degree in biochemistry from Saint-Petersburg State University and a doctorate in virology from the University of Helsinki.

Dr. Goloudina-Demidov serves as Clinical Trial Principal and researcher in immuno-oncology, responsible for overseeing trial conduct at investigational sites, coordinating with contract research organisations and investigators, ensuring source data verification and protocol adherence, maintaining trial documentation, and leading translational research connected to these trials. She brings over 20 years of research and development experience in cancer biology and immuno-oncology, having held post-doctoral fellowships at the Genome Institute of Singapore and the French National Institute of Health and Medical Research (INSERM), followed by roles as a Research Engineer at AP-HP Saint-Antoine Hospital and Laboratory Manager at Evotec in France. She holds a doctorate in biology from the Institute of Cytology of the Russian Academy of Sciences.